Quantum Computing Investment Accounting

Quantum Computing Investment Accounting: Measurement and

Recognition of Investments in Quantum Computing Technologies

Introduction

Quantum computing is emerging as one of the most promising yet disruptive technologies of

the 21st century with potential applications across diverse sectors from material sciences and

drug discovery to optimization, cybersecurity and artificial intelligence (McKinstrie et al.,

2021). However, developing quantum technologies involves long gestation periods, technical

complexity, and huge financial outlays owing to their underlying principles of quantum

mechanics which are vastly different from classical computing (Blank et al., 2021). As

Accounting Standards Board (FASB) and International Accounting Standards Board (IASB)

are yet to issue comprehensive guidelines on accounting for investments in emerging

technologies involving such high technical and commercialization risks. In absence of

definitive norms, individual companies have adopted diverse approaches leading to

inconsistencies in financial reporting. This assignment aims to explore pertinent issues

around investment accounting for quantum computing, propose potential measurement and

recognition frameworks, and discuss disclosure requirements to enhance transparency.

Measurement challenges

Measuring investments made in developing quantum computing capabilities poses unique

challenges compared to typical corporate expenditures. Unlike conventional information

engineers, and software developers.

Additionally, fast-paced technical advancements necessitate periodic reassessment of

investment costs against shifting commercial expectations. Given these complexities,

accurately quantifying quantum asset values and associating them with future economic

benefits for accounting and reporting purposes is difficult. Simply capitalizing all

expenditures as research and development (R&D) assets as is done conventionally may

overstate balance sheets by not reflecting technical and commercialization risks ahead (Ernst

& Young, 2022). On the other hand, expensing costs entirely results in asymmetric reporting

by not capturing progress made. There is need for balanced frameworks which fairly reflect

underlying investment risks, capture progress, and ensure integrity of financial statements.

periods and uncertainties inherent in nascent technology development, various hurdles arise:

- Technical feasibility is highly uncertain at early research stages. Commercial readiness

remains to be validated even at later prototyping phases given multitude of scalability

challenges to be overcome (KPMG, 2021a).

- Intended economic benefits are difficult to quantify reliably at various investment phases

due to market unknowns around demand, deployment models as well as pace of obsolescence

of intermediate technologies.

- Asset lives are unpredictable necessitating frequent re-evaluation due to exponential

progress characteristic to emerging domains like quantum computing.

- Separating research costs from future development and commercialization efforts involves

Proposed measurement approaches

Given challenges, some balanced measurement techniques circumventing over/under-

capitalization risks could be:

1. Component accounting:

Investments are split into clearly identifiable basic research, applied research, development

and commercialization components. Each component is treated distinctly based on

measurement reliability and risk profiles - expensing research costs, conditional capitalization

of development, capitalized commercialization costs.

2. Stage-gating:

Investments pass through predefined technical and commercial milestones or 'stages'

capitalizable assets based on milestone achievement assessed periodically.

4. Markets-based valuation:

For later commercialization stages, market data points like comparable company valuations,

transaction multiples, funding rounds etc. provide indicative valuations as cross-checks for

reasonableness of book values.

The above options require judgment in application but assist balanced quantification

reflective of inherent risks over conventional binary treatments alone. They warrant

consideration as interim measurement frameworks until definitive accounting standards

evolve.

Proposed recognition approaches

Potential recognition options which consider measurement interpretability and risks include:

memorandum items outside balance sheet alongside performance disclosures until asset

4. Capitalizing limited quantum programs as "Intangible Research Projects in Progress" if

5. Recognition as internally generated intangible assets for advanced prototyping stages

demonstrating technical functionality, accompanied by robust impairment testing.

The above phased approaches attempt reasonable balance between recognition constraints

and need for transparency on long-term investments amid technical and market uncertainties.

They avoid understatement while ensuring integrity and consistency with prevailing

accounting principles.

- Accounting policies for expenditure capitalization, impairment testing, asset lives

- Assumptions used in measuring quantum asset values and assessing economic benefits

- Sensitivity of reported asset values and performance to key assumptions

- Commitments, milestones tied to funding and nature of cost-sharing arrangements

- Progress updates against technical and commercial milestones quarterly/annually

- Comparison of projected vs actual cash flows of completed projects

Ultimately, accounting standard setters will need to consider emerging practices, propose

disclosure requirements. Early industry consultations have commenced (FASB, 2021). Issues

around componentization, staged recognition, impairment testing, asset lives estimations and

amortization will require examination. Convergence of diverse company practices will aid

Standardization when technologies achieve maturity, alongside periodic updates, can balance

interests of preparers and financial statement users. Accounting for emerging technologies

has precedents in biotechnology which point to a staged approach being most practical.

Conclusion

In conclusion, measurement and recognition of significant investments made in quantum

Accounting standard setters need to progressively converge emerging practices in this

domain through ongoing industry engagements. This brings needed discipline and enhances

stakeholders’ ability to appraise companies funding long-term strategic programs at the

forefront of innovation.

the 21st century with potential applications across diverse sectors from material sciences and

drug discovery to optimization, cybersecurity and artificial intelligence (McKinstrie et al.,

2021). However, developing quantum technologies involves long gestation periods, technical

complexity, and huge financial outlays owing to their underlying principles of quantum

mechanics which are vastly different from classical computing (Blank et al., 2021). As

government and corporate funding into this nascent field rapidly scales up globally to billions

of dollars annually (Kavil, 2022), accounting for investments made at various stages assumes

greater significance.

Accounting Standards Board (FASB) and International Accounting Standards Board (IASB)

around investment accounting for quantum computing, propose potential measurement and

Measurement challenges

Measuring investments made in developing quantum computing capabilities poses unique

challenges compared to typical corporate expenditures. Unlike conventional information

technology investments whose benefits often materialize within budgeted timeframes, costs

commercial viability (Deloitte, 2019). Further, outputs at various intermediate stages like

achieving basic qubit control or demonstrating quantum advantage over classical machines

have limited stand-alone economic value. It also involves multi-disciplinary hardware and

algorithm collaborative work across quantum physicists, materials scientists, computer

engineers, and software developers.

Additionally, fast-paced technical advancements necessitate periodic reassessment of

& Young, 2022). On the other hand, expensing costs entirely results in asymmetric reporting

by not capturing progress made. There is need for balanced frameworks which fairly reflect

underlying investment risks, capture progress, and ensure integrity of financial statements.

Recognition challenges

Recognizing investments made in quantum technologies as assets on balance sheets requires

demonstration of fulfilment of key criteria specified under accounting standards like IAS 38

on Intangible Assets. These pertain to technical feasibility to complete asset development,

intent and ability to generate economic benefits, reliable measurement of costs, and

availability of adequate resources for completion. However, given long-term gestation

periods and uncertainties inherent in nascent technology development, various hurdles arise:

- Technical feasibility is highly uncertain at early research stages. Commercial readiness

due to market unknowns around demand, deployment models as well as pace of obsolescence

complex judgments with unclear demarcation.

scientific research towards engineering integration.

These ambiguities inhibit clear recognition of quantum investments as intangible assets based

on reasonably certain quantification and estimation of associated future economic benefits as

required under accounting norms. Novel recognition frameworks become imperative.

Proposed measurement approaches

Given challenges, some balanced measurement techniques circumventing over/under-

measurement reliability and risk profiles - expensing research costs, conditional capitalization

of development, capitalized commercialization costs.

2. Stage-gating:

Investments pass through predefined technical and commercial milestones or 'stages'

capitalizable assets based on milestone achievement assessed periodically.

3. Probability-weighting:

Future cash flow estimation techniques factor progressive percentage probabilities of

technical and commercial success at investment stage. Resultant present values provide

balanced measurement reflecting risk.

4. Markets-based valuation:

The above options require judgment in application but assist balanced quantification

Proposed recognition approaches

Potential recognition options which consider measurement interpretability and risks include:

commercialization milestones if associated costs can be reliably measured and future benefits

reasonably estimated.

2. Presenting conditional non-cancellable purchase commitments for future developmental

spends as off-balance sheet obligations with comprehensive disclosures.

3. Disclosure of quantum programs through 'Research in Progress' caption or as

memorandum items outside balance sheet alongside performance disclosures until asset

The above phased approaches attempt reasonable balance between recognition constraints

and need for transparency on long-term investments amid technical and market uncertainties.

They avoid understatement while ensuring integrity and consistency with prevailing

accounting principles.

Disclosure requirements

Given measurement and recognition complexities, fulsome disclosures assume special

significance for quantum investment accounting. Key suggested areas for comprehensive

qualitative and quantitative disclosures are:

- Description of quantum programs portfolio and stages of development

- Risks and uncertainties in reasonably estimating future cash flows

- Comparison of projected vs actual cash flows of completed projects

- Details of impairments recorded and indicators for future impairments

- Data on comparable company valuations and transaction multiples

- Strategic objectives, targets, and timelines for commercial deployments

Robust disclosures provide transparency on measurement estimates for performance

evaluation and risks to recognized asset values, enhancing credibility and oversight.

consistency and comparability while remaining responsive to inherent quantum uncertainties.

Standardization when technologies achieve maturity, alongside periodic updates, can balance

interests of preparers and financial statement users. Accounting for emerging technologies

has precedents in biotechnology which point to a staged approach being most practical.

In conclusion, measurement and recognition of significant investments made in quantum

computing technologies present special challenges hitherto unaddressed adequately by

existing accounting frameworks. This necessitates frameworks balancing rigidity versus

flexibility, and transparency versus risk-overstatement. Staged, component and probability-

based measurement approaches coupled with milestone-based conditional recognition and

comprehensive qualitative-quantitative disclosures attempt reasonably balanced solutions.

Accounting standard setters need to progressively converge emerging practices in this

Quantum computing is emerging as one of the most promising yet disruptive technologies of

mechanics which are vastly different from classical computing (Blank et al., 2021). As

of dollars annually (Kavil, 2022), accounting for investments made at various stages assumes

greater significance.

This highlights the need to establish clear accounting principles to measure investments made

in developing quantum computing capabilities and recognizing associated assets consistently

in corporate financial statements. Recognized accounting standards setters like the Financial

3. Probability-weighting:

Future cash flow estimation techniques factor progressive percentage probabilities of

technical and commercial success at investment stage. Resultant present values provide

balanced measurement reflecting risk.

4. Markets-based valuation:

reflective of inherent risks over conventional binary treatments alone. They warrant

consideration as interim measurement frameworks until definitive accounting standards

evolve.

Proposed recognition approaches

Potential recognition options which consider measurement interpretability and risks include:

1. Capitalization as intangible development assets on achievement of key technological and

commercialization milestones if associated costs can be reliably measured and future benefits

reasonably estimated.

2. Presenting conditional non-cancellable purchase commitments for future developmental

spends as off-balance sheet obligations with comprehensive disclosures.

demonstrating technical functionality, accompanied by robust impairment testing.

The above phased approaches attempt reasonable balance between recognition constraints

and need for transparency on long-term investments amid technical and market uncertainties.

accounting principles.

Disclosure requirements

Given measurement and recognition complexities, fulsome disclosures assume special

significance for quantum investment accounting. Key suggested areas for comprehensive

qualitative and quantitative disclosures are:

- Description of quantum programs portfolio and stages of development

- Accounting policies for expenditure capitalization, impairment testing, asset lives

- Sensitivity of reported asset values and performance to key assumptions

- Commitments, milestones tied to funding and nature of cost-sharing arrangements

- Progress updates against technical and commercial milestones quarterly/annually

- Comparison of projected vs actual cash flows of completed projects

- Details of impairments recorded and indicators for future impairments

- Data on comparable company valuations and transaction multiples

- Strategic objectives, targets, and timelines for commercial deployments

amortization will require examination. Convergence of diverse company practices will aid

Standardization when technologies achieve maturity, alongside periodic updates, can balance

interests of preparers and financial statement users. Accounting for emerging technologies

Conclusion

In conclusion, measurement and recognition of significant investments made in quantum

computing technologies present special challenges hitherto unaddressed adequately by

existing accounting frameworks. This necessitates frameworks balancing rigidity versus

flexibility, and transparency versus risk-overstatement. Staged, component and probability-

based measurement approaches coupled with milestone-based conditional recognition and

Accounting standard setters need to progressively converge emerging practices in this

the 21st century with potential applications across diverse sectors from material sciences and

drug discovery to optimization, cybersecurity and artificial intelligence (McKinstrie et al.,

2021). However, developing quantum technologies involves long gestation periods, technical

complexity, and huge financial outlays owing to their underlying principles of quantum

mechanics which are vastly different from classical computing (Blank et al., 2021). As

of dollars annually (Kavil, 2022), accounting for investments made at various stages assumes

greater significance.

This highlights the need to establish clear accounting principles to measure investments made

in developing quantum computing capabilities and recognizing associated assets consistently

in corporate financial statements. Recognized accounting standards setters like the Financial

Accounting Standards Board (FASB) and International Accounting Standards Board (IASB)

are yet to issue comprehensive guidelines on accounting for investments in emerging

recognition frameworks, and discuss disclosure requirements to enhance transparency.

challenges compared to typical corporate expenditures. Unlike conventional information

incurred in quantum programs spread over years of research with uncertain prospects of

commercial viability (Deloitte, 2019). Further, outputs at various intermediate stages like

have limited stand-alone economic value. It also involves multi-disciplinary hardware and

algorithm collaborative work across quantum physicists, materials scientists, computer

engineers, and software developers.

Additionally, fast-paced technical advancements necessitate periodic reassessment of

investment costs against shifting commercial expectations. Given these complexities,

accurately quantifying quantum asset values and associating them with future economic

benefits for accounting and reporting purposes is difficult. Simply capitalizing all

expenditures as research and development (R&D) assets as is done conventionally may

& Young, 2022). On the other hand, expensing costs entirely results in asymmetric reporting

Recognizing investments made in quantum technologies as assets on balance sheets requires

demonstration of fulfilment of key criteria specified under accounting standards like IAS 38

on Intangible Assets. These pertain to technical feasibility to complete asset development,

intent and ability to generate economic benefits, reliable measurement of costs, and

availability of adequate resources for completion. However, given long-term gestation

- Technical feasibility is highly uncertain at early research stages. Commercial readiness

remains to be validated even at later prototyping phases given multitude of scalability

challenges to be overcome (KPMG, 2021a).

- Intended economic benefits are difficult to quantify reliably at various investment phases

due to market unknowns around demand, deployment models as well as pace of obsolescence

of intermediate technologies.

- Separating research costs from future development and commercialization efforts involves

on reasonably certain quantification and estimation of associated future economic benefits as

required under accounting norms. Novel recognition frameworks become imperative.

Proposed measurement approaches

Given challenges, some balanced measurement techniques circumventing over/under-

1. Component accounting:

Investments are split into clearly identifiable basic research, applied research, development

and commercialization components. Each component is treated distinctly based on

measurement reliability and risk profiles - expensing research costs, conditional capitalization

3. Probability-weighting:

Future cash flow estimation techniques factor progressive percentage probabilities of

technical and commercial success at investment stage. Resultant present values provide

balanced measurement reflecting risk.

For later commercialization stages, market data points like comparable company valuations,

transaction multiples, funding rounds etc. provide indicative valuations as cross-checks for

reasonableness of book values.

The above options require judgment in application but assist balanced quantification

reflective of inherent risks over conventional binary treatments alone. They warrant

consideration as interim measurement frameworks until definitive accounting standards

evolve.

2. Presenting conditional non-cancellable purchase commitments for future developmental

3. Disclosure of quantum programs through 'Research in Progress' caption or as

recognition criteria are met.

4. Capitalizing limited quantum programs as "Intangible Research Projects in Progress" if

5. Recognition as internally generated intangible assets for advanced prototyping stages

demonstrating technical functionality, accompanied by robust impairment testing.

The above phased approaches attempt reasonable balance between recognition constraints

They avoid understatement while ensuring integrity and consistency with prevailing

significance for quantum investment accounting. Key suggested areas for comprehensive

qualitative and quantitative disclosures are:

- Description of quantum programs portfolio and stages of development

- Assumptions used in measuring quantum asset values and assessing economic benefits

- Risks and uncertainties in reasonably estimating future cash flows

- Sensitivity of reported asset values and performance to key assumptions

- Commitments, milestones tied to funding and nature of cost-sharing arrangements

- Strategic objectives, targets, and timelines for commercial deployments

Robust disclosures provide transparency on measurement estimates for performance

evaluation and risks to recognized asset values, enhancing credibility and oversight.

Convergence of accounting standards

Ultimately, accounting standard setters will need to consider emerging practices, propose

disclosure requirements. Early industry consultations have commenced (FASB, 2021). Issues

around componentization, staged recognition, impairment testing, asset lives estimations and

amortization will require examination. Convergence of diverse company practices will aid

consistency and comparability while remaining responsive to inherent quantum uncertainties.

Standardization when technologies achieve maturity, alongside periodic updates, can balance

has precedents in biotechnology which point to a staged approach being most practical.

existing accounting frameworks. This necessitates frameworks balancing rigidity versus

flexibility, and transparency versus risk-overstatement. Staged, component and probability-

based measurement approaches coupled with milestone-based conditional recognition and

comprehensive qualitative-quantitative disclosures attempt reasonably balanced solutions.

Accounting standard setters need to progressively converge emerging practices in this

stakeholders’ ability to appraise companies funding long-term strategic programs at the

forefront of innovation.

Quantum computing is emerging as one of the most promising yet disruptive technologies of

the 21st century with potential applications across diverse sectors from material sciences and

drug discovery to optimization, cybersecurity and artificial intelligence (McKinstrie et al.,

2021). However, developing quantum technologies involves long gestation periods, technical

complexity, and huge financial outlays owing to their underlying principles of quantum

are yet to issue comprehensive guidelines on accounting for investments in emerging

definitive norms, individual companies have adopted diverse approaches leading to

inconsistencies in financial reporting. This assignment aims to explore pertinent issues

recognition frameworks, and discuss disclosure requirements to enhance transparency.

Measurement challenges

Measuring investments made in developing quantum computing capabilities poses unique

challenges compared to typical corporate expenditures. Unlike conventional information

technology investments whose benefits often materialize within budgeted timeframes, costs

incurred in quantum programs spread over years of research with uncertain prospects of

commercial viability (Deloitte, 2019). Further, outputs at various intermediate stages like

have limited stand-alone economic value. It also involves multi-disciplinary hardware and

accurately quantifying quantum asset values and associating them with future economic

benefits for accounting and reporting purposes is difficult. Simply capitalizing all

expenditures as research and development (R&D) assets as is done conventionally may

overstate balance sheets by not reflecting technical and commercialization risks ahead (Ernst

& Young, 2022). On the other hand, expensing costs entirely results in asymmetric reporting

underlying investment risks, capture progress, and ensure integrity of financial statements.

Recognition challenges

Recognizing investments made in quantum technologies as assets on balance sheets requires

demonstration of fulfilment of key criteria specified under accounting standards like IAS 38

on Intangible Assets. These pertain to technical feasibility to complete asset development,

intent and ability to generate economic benefits, reliable measurement of costs, and

remains to be validated even at later prototyping phases given multitude of scalability

of intermediate technologies.

- Asset lives are unpredictable necessitating frequent re-evaluation due to exponential

progress characteristic to emerging domains like quantum computing.

- Separating research costs from future development and commercialization efforts involves

complex judgments with unclear demarcation.

- Valuation dependability decreases as investment work moves away from proven basic

scientific research towards engineering integration.

These ambiguities inhibit clear recognition of quantum investments as intangible assets based

on reasonably certain quantification and estimation of associated future economic benefits as

1. Component accounting:

Investments are split into clearly identifiable basic research, applied research, development

and commercialization components. Each component is treated distinctly based on

measurement reliability and risk profiles - expensing research costs, conditional capitalization

of development, capitalized commercialization costs.

2. Stage-gating:

Investments pass through predefined technical and commercial milestones or 'stages'

determined objectively. Costs before a stage are expensed, costs after are potentially

capitalizable assets based on milestone achievement assessed periodically.

3. Probability-weighting:

Future cash flow estimation techniques factor progressive percentage probabilities of

technical and commercial success at investment stage. Resultant present values provide

transaction multiples, funding rounds etc. provide indicative valuations as cross-checks for

consideration as interim measurement frameworks until definitive accounting standards

Proposed recognition approaches

Potential recognition options which consider measurement interpretability and risks include:

1. Capitalization as intangible development assets on achievement of key technological and

commercialization milestones if associated costs can be reliably measured and future benefits

reasonably estimated.

2. Presenting conditional non-cancellable purchase commitments for future developmental

isolation criteria for identifiable R&D assets under joint development arrangements are met.

5. Recognition as internally generated intangible assets for advanced prototyping stages

demonstrating technical functionality, accompanied by robust impairment testing.

and need for transparency on long-term investments amid technical and market uncertainties.

They avoid understatement while ensuring integrity and consistency with prevailing

accounting principles.

Disclosure requirements

Given measurement and recognition complexities, fulsome disclosures assume special

significance for quantum investment accounting. Key suggested areas for comprehensive

- Accounting policies for expenditure capitalization, impairment testing, asset lives

- Commitments, milestones tied to funding and nature of cost-sharing arrangements

- Progress updates against technical and commercial milestones quarterly/annually

- Comparison of projected vs actual cash flows of completed projects

by not capturing progress made. There is need for balanced frameworks which fairly reflect

underlying investment risks, capture progress, and ensure integrity of financial statements.

Recognition challenges

demonstration of fulfilment of key criteria specified under accounting standards like IAS 38

- Technical feasibility is highly uncertain at early research stages. Commercial readiness

remains to be validated even at later prototyping phases given multitude of scalability

challenges to be overcome (KPMG, 2021a).

- Intended economic benefits are difficult to quantify reliably at various investment phases

of intermediate technologies.

- Asset lives are unpredictable necessitating frequent re-evaluation due to exponential

progress characteristic to emerging domains like quantum computing.

- Separating research costs from future development and commercialization efforts involves

complex judgments with unclear demarcation.

on reasonably certain quantification and estimation of associated future economic benefits as

Given challenges, some balanced measurement techniques circumventing over/under-

1. Component accounting:

and commercialization components. Each component is treated distinctly based on

measurement reliability and risk profiles - expensing research costs, conditional capitalization

of development, capitalized commercialization costs.

2. Stage-gating:

Investments pass through predefined technical and commercial milestones or 'stages'

determined objectively. Costs before a stage are expensed, costs after are potentially

capitalizable assets based on milestone achievement assessed periodically.

Future cash flow estimation techniques factor progressive percentage probabilities of

transaction multiples, funding rounds etc. provide indicative valuations as cross-checks for

reasonableness of book values.

The above options require judgment in application but assist balanced quantification

reflective of inherent risks over conventional binary treatments alone. They warrant

evolve.

Proposed recognition approaches

Potential recognition options which consider measurement interpretability and risks include:

1. Capitalization as intangible development assets on achievement of key technological and

commercialization milestones if associated costs can be reliably measured and future benefits

4. Capitalizing limited quantum programs as "Intangible Research Projects in Progress" if

5. Recognition as internally generated intangible assets for advanced prototyping stages

The above phased approaches attempt reasonable balance between recognition constraints

and need for transparency on long-term investments amid technical and market uncertainties.

They avoid understatement while ensuring integrity and consistency with prevailing

accounting principles.

Disclosure requirements

significance for quantum investment accounting. Key suggested areas for comprehensive

- Assumptions used in measuring quantum asset values and assessing economic benefits

- Risks and uncertainties in reasonably estimating future cash flows

- Commitments, milestones tied to funding and nature of cost-sharing arrangements

- Progress updates against technical and commercial milestones quarterly/annually

- Comparison of projected vs actual cash flows of completed projects

- Details of impairments recorded and indicators for future impairments

definitive guidelines on measurement and recognition along with uniform reporting and

disclosure requirements. Early industry consultations have commenced (FASB, 2021). Issues

amortization will require examination. Convergence of diverse company practices will aid

consistency and comparability while remaining responsive to inherent quantum uncertainties.

Standardization when technologies achieve maturity, alongside periodic updates, can balance

interests of preparers and financial statement users. Accounting for emerging technologies

has precedents in biotechnology which point to a staged approach being most practical.

Conclusion

computing technologies present special challenges hitherto unaddressed adequately by

domain through ongoing industry engagements. This brings needed discipline and enhances

stakeholders’ ability to appraise companies funding long-term strategic programs at the

forefront of innovation.

Quantum computing is emerging as one of the most promising yet disruptive technologies of

drug discovery to optimization, cybersecurity and artificial intelligence (McKinstrie et al.,

2021). However, developing quantum technologies involves long gestation periods, technical

complexity, and huge financial outlays owing to their underlying principles of quantum

mechanics which are vastly different from classical computing (Blank et al., 2021). As

government and corporate funding into this nascent field rapidly scales up globally to billions

of dollars annually (Kavil, 2022), accounting for investments made at various stages assumes

greater significance.

are yet to issue comprehensive guidelines on accounting for investments in emerging

recognition frameworks, and discuss disclosure requirements to enhance transparency.

Measurement challenges

challenges compared to typical corporate expenditures. Unlike conventional information

technology investments whose benefits often materialize within budgeted timeframes, costs

incurred in quantum programs spread over years of research with uncertain prospects of

achieving basic qubit control or demonstrating quantum advantage over classical machines

have limited stand-alone economic value. It also involves multi-disciplinary hardware and

algorithm collaborative work across quantum physicists, materials scientists, computer

engineers, and software developers.

investment costs against shifting commercial expectations. Given these complexities,

by not capturing progress made. There is need for balanced frameworks which fairly reflect

underlying investment risks, capture progress, and ensure integrity of financial statements.

Recognition challenges

demonstration of fulfilment of key criteria specified under accounting standards like IAS 38

on Intangible Assets. These pertain to technical feasibility to complete asset development,

intent and ability to generate economic benefits, reliable measurement of costs, and

availability of adequate resources for completion. However, given long-term gestation

periods and uncertainties inherent in nascent technology development, various hurdles arise:

- Technical feasibility is highly uncertain at early research stages. Commercial readiness

remains to be validated even at later prototyping phases given multitude of scalability

of intermediate technologies.

- Separating research costs from future development and commercialization efforts involves

- Valuation dependability decreases as investment work moves away from proven basic

These ambiguities inhibit clear recognition of quantum investments as intangible assets based

on reasonably certain quantification and estimation of associated future economic benefits as

Proposed measurement approaches

Given challenges, some balanced measurement techniques circumventing over/under-

capitalization risks could be:

1. Component accounting:

2. Stage-gating:

Investments pass through predefined technical and commercial milestones or 'stages'

determined objectively. Costs before a stage are expensed, costs after are potentially

capitalizable assets based on milestone achievement assessed periodically.

Future cash flow estimation techniques factor progressive percentage probabilities of

technical and commercial success at investment stage. Resultant present values provide

balanced measurement reflecting risk.

4. Markets-based valuation:

For later commercialization stages, market data points like comparable company valuations,

transaction multiples, funding rounds etc. provide indicative valuations as cross-checks for

reasonableness of book values.

evolve.

commercialization milestones if associated costs can be reliably measured and future benefits

reasonably estimated.

2. Presenting conditional non-cancellable purchase commitments for future developmental

spends as off-balance sheet obligations with comprehensive disclosures.

3. Disclosure of quantum programs through 'Research in Progress' caption or as

memorandum items outside balance sheet alongside performance disclosures until asset

recognition criteria are met.

4. Capitalizing limited quantum programs as "Intangible Research Projects in Progress" if

They avoid understatement while ensuring integrity and consistency with prevailing

accounting principles.

Disclosure requirements

significance for quantum investment accounting. Key suggested areas for comprehensive

qualitative and quantitative disclosures are:

- Description of quantum programs portfolio and stages of development

- Accounting policies for expenditure capitalization, impairment testing, asset lives

- Assumptions used in measuring quantum asset values and assessing economic benefits

- Comparison of projected vs actual cash flows of completed projects

- Details of impairments recorded and indicators for future impairments

- Strategic objectives, targets, and timelines for commercial deployments

Robust disclosures provide transparency on measurement estimates for performance

evaluation and risks to recognized asset values, enhancing credibility and oversight.

Convergence of accounting standards

definitive guidelines on measurement and recognition along with uniform reporting and

interests of preparers and financial statement users. Accounting for emerging technologies

has precedents in biotechnology which point to a staged approach being most practical.

Conclusion

computing technologies present special challenges hitherto unaddressed adequately by

existing accounting frameworks. This necessitates frameworks balancing rigidity versus

flexibility, and transparency versus risk-overstatement. Staged, component and probability-

based measurement approaches coupled with milestone-based conditional recognition and

comprehensive qualitative-quantitative disclosures attempt reasonably balanced solutions.

Accounting standard setters need to progressively converge emerging practices in this

domain through ongoing industry engagements. This brings needed discipline and enhances

stakeholders’ ability to appraise companies funding long-term strategic programs at the

drug discovery to optimization, cybersecurity and artificial intelligence (McKinstrie et al.,

of dollars annually (Kavil, 2022), accounting for investments made at various stages assumes

This highlights the need to establish clear accounting principles to measure investments made

in corporate financial statements. Recognized accounting standards setters like the Financial

Accounting Standards Board (FASB) and International Accounting Standards Board (IASB)

are yet to issue comprehensive guidelines on accounting for investments in emerging

definitive norms, individual companies have adopted diverse approaches leading to

inconsistencies in financial reporting. This assignment aims to explore pertinent issues

around investment accounting for quantum computing, propose potential measurement and

recognition frameworks, and discuss disclosure requirements to enhance transparency.

achieving basic qubit control or demonstrating quantum advantage over classical machines

have limited stand-alone economic value. It also involves multi-disciplinary hardware and

algorithm collaborative work across quantum physicists, materials scientists, computer

engineers, and software developers.

investment costs against shifting commercial expectations. Given these complexities,

accurately quantifying quantum asset values and associating them with future economic

benefits for accounting and reporting purposes is difficult. Simply capitalizing all

expenditures as research and development (R&D) assets as is done conventionally may

overstate balance sheets by not reflecting technical and commercialization risks ahead (Ernst

& Young, 2022). On the other hand, expensing costs entirely results in asymmetric reporting

by not capturing progress made. There is need for balanced frameworks which fairly reflect

underlying investment risks, capture progress, and ensure integrity of financial statements.

demonstration of fulfilment of key criteria specified under accounting standards like IAS 38

remains to be validated even at later prototyping phases given multitude of scalability

challenges to be overcome (KPMG, 2021a).

- Intended economic benefits are difficult to quantify reliably at various investment phases

due to market unknowns around demand, deployment models as well as pace of obsolescence

of intermediate technologies.

- Asset lives are unpredictable necessitating frequent re-evaluation due to exponential

progress characteristic to emerging domains like quantum computing.

- Separating research costs from future development and commercialization efforts involves

complex judgments with unclear demarcation.

- Valuation dependability decreases as investment work moves away from proven basic

Proposed measurement approaches

Given challenges, some balanced measurement techniques circumventing over/under-

capitalization risks could be:

1. Component accounting:

Investments are split into clearly identifiable basic research, applied research, development

and commercialization components. Each component is treated distinctly based on

measurement reliability and risk profiles - expensing research costs, conditional capitalization

of development, capitalized commercialization costs.

2. Stage-gating:

Investments pass through predefined technical and commercial milestones or 'stages'

Future cash flow estimation techniques factor progressive percentage probabilities of

For later commercialization stages, market data points like comparable company valuations,

reasonableness of book values.

reflective of inherent risks over conventional binary treatments alone. They warrant

consideration as interim measurement frameworks until definitive accounting standards

evolve.

Accounting standard setters need to progressively converge emerging practices in this

domain through ongoing industry engagements. This brings needed discipline and enhances

stakeholders’ ability to appraise companies funding long-term strategic programs at the

forefront of innovation.

the 21st century with potential applications across diverse sectors from material sciences and

of dollars annually (Kavil, 2022), accounting for investments made at various stages assumes

greater significance.

This highlights the need to establish clear accounting principles to measure investments made

in developing quantum computing capabilities and recognizing associated assets consistently

Accounting Standards Board (FASB) and International Accounting Standards Board (IASB)

are yet to issue comprehensive guidelines on accounting for investments in emerging

technologies involving such high technical and commercialization risks. In absence of

definitive norms, individual companies have adopted diverse approaches leading to

inconsistencies in financial reporting. This assignment aims to explore pertinent issues

around investment accounting for quantum computing, propose potential measurement and

recognition frameworks, and discuss disclosure requirements to enhance transparency.

technology investments whose benefits often materialize within budgeted timeframes, costs

algorithm collaborative work across quantum physicists, materials scientists, computer

Additionally, fast-paced technical advancements necessitate periodic reassessment of

accurately quantifying quantum asset values and associating them with future economic

benefits for accounting and reporting purposes is difficult. Simply capitalizing all

expenditures as research and development (R&D) assets as is done conventionally may

& Young, 2022). On the other hand, expensing costs entirely results in asymmetric reporting

by not capturing progress made. There is need for balanced frameworks which fairly reflect

underlying investment risks, capture progress, and ensure integrity of financial statements.

Recognition challenges

Recognizing investments made in quantum technologies as assets on balance sheets requires

- Technical feasibility is highly uncertain at early research stages. Commercial readiness

remains to be validated even at later prototyping phases given multitude of scalability

challenges to be overcome (KPMG, 2021a).

due to market unknowns around demand, deployment models as well as pace of obsolescence

of intermediate technologies.

- Asset lives are unpredictable necessitating frequent re-evaluation due to exponential

progress characteristic to emerging domains like quantum computing.

- Separating research costs from future development and commercialization efforts involves

complex judgments with unclear demarcation.

These ambiguities inhibit clear recognition of quantum investments as intangible assets based

capitalization risks could be:

Investments are split into clearly identifiable basic research, applied research, development

and commercialization components. Each component is treated distinctly based on

measurement reliability and risk profiles - expensing research costs, conditional capitalization

2. Stage-gating:

Investments pass through predefined technical and commercial milestones or 'stages'

determined objectively. Costs before a stage are expensed, costs after are potentially

capitalizable assets based on milestone achievement assessed periodically.

3. Probability-weighting:

For later commercialization stages, market data points like comparable company valuations,

transaction multiples, funding rounds etc. provide indicative valuations as cross-checks for

reasonableness of book values.

The above options require judgment in application but assist balanced quantification

consideration as interim measurement frameworks until definitive accounting standards

evolve.

Proposed recognition approaches

Potential recognition options which consider measurement interpretability and risks include:

1. Capitalization as intangible development assets on achievement of key technological and

spends as off-balance sheet obligations with comprehensive disclosures.

isolation criteria for identifiable R&D assets under joint development arrangements are met.

demonstrating technical functionality, accompanied by robust impairment testing.

The above phased approaches attempt reasonable balance between recognition constraints

They avoid understatement while ensuring integrity and consistency with prevailing

accounting principles.

Disclosure requirements

significance for quantum investment accounting. Key suggested areas for comprehensive

- Assumptions used in measuring quantum asset values and assessing economic benefits

- Risks and uncertainties in reasonably estimating future cash flows

- Commitments, milestones tied to funding and nature of cost-sharing arrangements

- Progress updates against technical and commercial milestones quarterly/annually

- Comparison of projected vs actual cash flows of completed projects

- Details of impairments recorded and indicators for future impairments

definitive guidelines on measurement and recognition along with uniform reporting and

disclosure requirements. Early industry consultations have commenced (FASB, 2021). Issues

amortization will require examination. Convergence of diverse company practices will aid

consistency and comparability while remaining responsive to inherent quantum uncertainties.

Standardization when technologies achieve maturity, alongside periodic updates, can balance

interests of preparers and financial statement users. Accounting for emerging technologies

has precedents in biotechnology which point to a staged approach being most practical.

Conclusion

computing technologies present special challenges hitherto unaddressed adequately by

domain through ongoing industry engagements. This brings needed discipline and enhances

stakeholders’ ability to appraise companies funding long-term strategic programs at the

forefront of innovation.

Quantum computing is emerging as one of the most promising yet disruptive technologies of

drug discovery to optimization, cybersecurity and artificial intelligence (McKinstrie et al.,

2021). However, developing quantum technologies involves long gestation periods, technical

complexity, and huge financial outlays owing to their underlying principles of quantum

mechanics which are vastly different from classical computing (Blank et al., 2021). As

government and corporate funding into this nascent field rapidly scales up globally to billions

of dollars annually (Kavil, 2022), accounting for investments made at various stages assumes

greater significance.

are yet to issue comprehensive guidelines on accounting for investments in emerging

recognition frameworks, and discuss disclosure requirements to enhance transparency.

Measurement challenges

challenges compared to typical corporate expenditures. Unlike conventional information

technology investments whose benefits often materialize within budgeted timeframes, costs

incurred in quantum programs spread over years of research with uncertain prospects of

achieving basic qubit control or demonstrating quantum advantage over classical machines

have limited stand-alone economic value. It also involves multi-disciplinary hardware and

algorithm collaborative work across quantum physicists, materials scientists, computer

engineers, and software developers.

investment costs against shifting commercial expectations. Given these complexities,

by not capturing progress made. There is need for balanced frameworks which fairly reflect

underlying investment risks, capture progress, and ensure integrity of financial statements.

Recognition challenges

demonstration of fulfilment of key criteria specified under accounting standards like IAS 38

on Intangible Assets. These pertain to technical feasibility to complete asset development,

intent and ability to generate economic benefits, reliable measurement of costs, and

availability of adequate resources for completion. However, given long-term gestation

periods and uncertainties inherent in nascent technology development, various hurdles arise:

- Technical feasibility is highly uncertain at early research stages. Commercial readiness

remains to be validated even at later prototyping phases given multitude of scalability

of intermediate technologies.

- Separating research costs from future development and commercialization efforts involves

- Valuation dependability decreases as investment work moves away from proven basic

These ambiguities inhibit clear recognition of quantum investments as intangible assets based

on reasonably certain quantification and estimation of associated future economic benefits as

Proposed measurement approaches

Given challenges, some balanced measurement techniques circumventing over/under-

capitalization risks could be:

1. Component accounting:

2. Stage-gating:

Investments pass through predefined technical and commercial milestones or 'stages'

determined objectively. Costs before a stage are expensed, costs after are potentially

capitalizable assets based on milestone achievement assessed periodically.

Future cash flow estimation techniques factor progressive percentage probabilities of

technical and commercial success at investment stage. Resultant present values provide

balanced measurement reflecting risk.

4. Markets-based valuation:

For later commercialization stages, market data points like comparable company valuations,

transaction multiples, funding rounds etc. provide indicative valuations as cross-checks for

reasonableness of book values.

evolve.

commercialization milestones if associated costs can be reliably measured and future benefits

reasonably estimated.

2. Presenting conditional non-cancellable purchase commitments for future developmental

spends as off-balance sheet obligations with comprehensive disclosures.

3. Disclosure of quantum programs through 'Research in Progress' caption or as

memorandum items outside balance sheet alongside performance disclosures until asset

recognition criteria are met.

4. Capitalizing limited quantum programs as "Intangible Research Projects in Progress" if

They avoid understatement while ensuring integrity and consistency with prevailing

accounting principles.

Disclosure requirements

significance for quantum investment accounting. Key suggested areas for comprehensive

qualitative and quantitative disclosures are:

- Description of quantum programs portfolio and stages of development

- Accounting policies for expenditure capitalization, impairment testing, asset lives

- Assumptions used in measuring quantum asset values and assessing economic benefits

- Comparison of projected vs actual cash flows of completed projects

- Details of impairments recorded and indicators for future impairments

- Strategic objectives, targets, and timelines for commercial deployments

Robust disclosures provide transparency on measurement estimates for performance

evaluation and risks to recognized asset values, enhancing credibility and oversight.

Convergence of accounting standards

definitive guidelines on measurement and recognition along with uniform reporting and

interests of preparers and financial statement users. Accounting for emerging technologies

has precedents in biotechnology which point to a staged approach being most practical.

Conclusion

computing technologies present special challenges hitherto unaddressed adequately by

existing accounting frameworks. This necessitates frameworks balancing rigidity versus

flexibility, and transparency versus risk-overstatement. Staged, component and probability-

based measurement approaches coupled with milestone-based conditional recognition and

comprehensive qualitative-quantitative disclosures attempt reasonably balanced solutions.

Accounting standard setters need to progressively converge emerging practices in this

domain through ongoing industry engagements. This brings needed discipline and enhances

stakeholders’ ability to appraise companies funding long-term strategic programs at the